Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippon Sanso Holdings is a Japanese public holding company that operates a global industrial, electronics, thermos, and medical gases business through subsidiaries including Taiyo Nippon Sanso, Matheson Tri-Gas, and Nippon Gases. In healthcare, the group supplies medical gases and related respiratory and home-therapy services, rather than developing therapeutic drug pipelines. Its business is commercial-stage and infrastructure-oriented, with capabilities spanning production, distribution, and plant engineering for oxygen, nitrogen, argon, specialty gases, and healthcare gas services. The company is part of the broader Mitsubishi Chemical Group and has a substantial international footprint across Asia, Europe, and the Americas. For biotech analyst purposes, this is best characterized as a commercial medical-gas and industrial-gas operator rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanso Holding.